Invesco S&P 500 Equal Weight Health Care ETF RSPH

The Motley Fool 7 nov

The article compares two healthcare ETFs: RSPH (Invesco S&P 500 Equal Weight Healthcare ETF) and XBI (State Street SPDR S&P Biotech ETF). RSPH offers broader healthcare sector diversification with lower volatility and higher dividend yield (0.56%), while XBI provides concentrated biotech exposure with higher short-term returns (39.6% 1-year) but steeper drawdowns (53.2% max). RSPH is recommended for conservative investors seeking stability, while XBI suits those with higher risk tolerance seeking biotech-specific growth.

The Motley Fool 26 oct

RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and IBB (iShares Biotechnology ETF) offer different approaches to healthcare investing. RSPH provides broader, equal-weighted healthcare exposure with lower volatility, higher dividend yield (0.6%), and a lower expense ratio (0.4%), making it suitable for risk-averse investors. IBB offers concentrated biotech exposure with stronger recent returns (35.5% vs 31.9%) but higher volatility and drawdown risk. The choice depends on investor risk tolerance and conviction in biotechnology's momentum.

The Motley Fool 25 oct

The article compares two healthcare ETFs: VanEck Biotech ETF (BBH), which concentrates on 25 biotech companies with higher volatility, and Invesco S&P 500 Equal Weight Health Care ETF (RSPH), which diversifies across 61 healthcare companies. While BBH showed stronger 1-year returns (38.3% vs 25.7%), RSPH is recommended for long-term investors due to lower concentration risk, broader diversification, and higher dividend yield, despite slightly higher expense ratios.

Zacks Investment Research 31 ago

RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternatives like VHT (0.09% expense ratio) and XLV (0.08% expense ratio) may be more suitable for cost-conscious investors seeking lower-risk options.

The Motley Fool 21 jul

IXJ and RSPH are two healthcare ETFs with different strategies: IXJ uses cap-weighted global exposure with larger pharmaceutical companies, offering higher dividends (1.47%) and lower volatility (beta 0.52), while RSPH employs equal-weighting of S&P 500 healthcare stocks, providing stronger 1-year returns (21.01% vs 18.29%) but higher risk (beta 0.81). The choice depends on investor goals—IXJ suits conservative/income-focused investors, while RSPH appeals to growth-oriented investors willing to accept volatility.